# A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

> **NCT05669950** · PHASE1,PHASE2 · RECRUITING · sponsor: **H. Lundbeck A/S** · enrollment: 42 (estimated)

## Conditions studied

- Congenital Adrenal Hyperplasia

## Interventions

- **DRUG:** Lu AG13909

## Key facts

- **NCT ID:** NCT05669950
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-19
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05669950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05669950, "A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT05669950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*